Janus International Group Reports Third Quarter 2022 Financial Results
Janus International Group reported a strong third quarter for 2022, achieving a 39.8% increase in revenue to $262.5 million. Key growth drivers included a 58.3% rise in the Commercial and Other segment and a 49.1% increase in Restore, Rebuild & Replace (R3). Adjusted EBITDA surged 74.3% to $63.3 million, with a margin improvement of 480 basis points. Net income also doubled, reaching $32.4 million. Janus raised its full-year outlook, projecting revenues of $990 million to $1.01 billion and Adjusted EBITDA of $218 million to $225 million.
- 39.8% revenue growth to $262.5 million.
- Adjusted EBITDA increased by 74.3% to $63.3 million.
- Net income grew over 108% to $32.4 million.
- Raised full-year 2022 revenue outlook to $990 million - $1.01 billion, a 33.3% increase at midpoint.
- Adjusted EBITDA guidance raised to $218 million - $225 million, a 49.5% increase at midpoint.
- Inflationary increases in raw material, labor, and logistics costs impacting margins.
Delivered
Delivered over
Adjusted EBITDA margin improvement of approximately 480 basis points
Net Income growth of over
Raises full-year 2022 revenue and Adjusted EBITDA outlook
Third Quarter 2022 Highlights
-
Revenues of
, a$262.5 million 39.8% increase compared to for the third quarter of 2021, driven primarily by strong performance across all sales channels, including Commercial and Other up$187.8 million 58.3% , Restore, Rebuild & Replace (“R3”) up49.1% , andNew Construction up13.8% . The 2021 acquisitions of DBCI and ACT contributed to revenue growth.$8.7 million
-
Adjusted EBITDA (defined as net income plus the corresponding add-backs shown in the Adjusted EBITDA reconciliation tables below) of
, a$63.3 million 74.3% increase compared to for the third quarter of 2021, driven by increased revenue from all sales channels, partially offset by incremental general and administrative expenses. Adjusted EBITDA as a percentage of revenues was$36.3 million 24.1% , an increase of approximately 480 basis points from the prior year period due primarily to increased revenue from commercial actions and higher volumes, partially offset by inflationary increases in raw material, labor and logistics costs, as well as incremental costs associated with the robust pace of activity for the balance of the year and investing in customer service.
-
Net income was
, or$32.4 million per diluted share, compared to a$0.22 , or$15.5 million per diluted share in the third quarter of 2021.$0.10
-
Adjusted Net Income (defined as Net Income plus the corresponding tax-adjusted add-backs shown in the Adjusted Net Income reconciliation tables below) was
, up$32.3 million 111.4% compared to in the third quarter of 2021. Adjusted Net Income per diluted share was$15.3 million , compared to$0.22 per diluted share in the prior year quarter.$0.11
-
Operating cash flow of
compared to$19.4 million in the third quarter of 2021. Free cash flow was$14.9 million compared to$16.8 million in the third quarter of 2021, representing a free cash flow conversion of$2.9 million 52% of Adjusted Net Income, that included continued investments in working capital to support the ongoing growth of the business.
- Quarter end leverage ratio of 3.3x – a decrease of .6x from Q2 2022, with continued focus on maintaining leverage within our target range of 2.5x - 3.5x.
2022 Financial Outlook:
Based on the Company’s current business outlook, Janus is raising its full-year 2022 outlook as follows:
-
Revenue in a range of
to$990 million , up from the previous range of$1.01 billion to$940 million . The new range represents a$960 million 33.3% increase at the midpoint as compared to 2021 levels.
-
Adjusted EBITDA in a range of
to$218 million , up from the previous range of$225 million to$204 million . The new range represents a$211 million 49.5% increase at the midpoint as compared to 2021 levels.
About
Conference Call and Webcast
The Company will host a conference call and webcast to review third quarter results, discuss recent events and conduct a question-and-answer session on
Forward Looking Statements
Certain statements in this communication, including the estimated guidance provided under “2022 Financial Outlook” herein, may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact included in this communication are forward-looking statements, including, but not limited to statements regarding Janus’s positioning in the industry to strengthen its pipeline and deliver on its objectives and Janus’s belief regarding the demand outlook for Janus’s products and the strength of the industrials markets. When used in this communication, words such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions, as they relate to the management team, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of Janus’s management, based on currently available information, as to the outcome and timing of future events, and involve factors, risks, and uncertainties that may cause actual results in future periods to differ materially from such statements.
In addition to factors previously disclosed in Janus’s reports filed with the
There can be no assurance that the events, results, trends or guidance regarding financial outlook identified in these forward-looking statements will occur or be achieved. Forward-looking statements speak only as of the date they are made, and Janus is not under any obligation and expressly disclaims any obligation, to update, alter or otherwise revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. This communication is not intended to be all-inclusive or to contain all the information that a person may desire in considering an investment in Janus and is not intended to form the basis of an investment decision in Janus. All subsequent written and oral forward-looking statements concerning Janus or other matters and attributable to Janus or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above and under the heading “Risk Factors” in Janus’s most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q, as updated from time to time in amendments and its subsequent filings with the
Non-GAAP Financial Measures
Janus uses measures of performance that are not required by or presented in accordance with GAAP in
Adjusted EBITDA, Adjusted Net Income, Adjusted Basic EPS, and Adjusted Diluted EPS are non-GAAP financial measures used by Janus to evaluate its operating performance, generate future operating plans, and make strategic decisions, including those relating to operating expenses and the allocation of internal resources. Accordingly, Janus believes Adjusted EBITDA, Adjusted Net Income, Adjusted Basic EPS, and Adjusted Diluted EPS provide useful information to investors and others in understanding and evaluating Janus’s operating results in the same manner as its management and board of directors and in comparison with Janus’s peer group companies. In addition, Adjusted EBITDA, Adjusted Net Income, Adjusted Basic EPS, and Adjusted Diluted EPS provide useful measures for period-to-period comparisons of Janus’s business, as they remove the effect of certain non-recurring events and other non-recurring charges, such as acquisitions, and certain variable or non-recurring charges. Adjusted EBITDA is defined as net income excluding interest expense, income taxes, depreciation expense, amortization, and other non-operational, non-recurring items. Adjusted Net Income is defined as net income plus the corresponding tax-adjusted add-backs shown in the Adjusted EBITDA reconciliation. Adjusted Basic earnings (income) per share (EPS) is computed by taking Adjusted Net Income divided by the weighted average number of shares of common stock outstanding during the period. Adjusted Diluted earnings (income) per share (EPS) is computed by dividing Adjusted Net Income by the weighted average number of common shares outstanding plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method. Dilutive potential common shares include stock purchase warrants and contingently issuable shares attributable to the earn-out consideration.
Adjusted EBITDA, Adjusted Net Income, Adjusted Basic EPS, and Adjusted Diluted EPS should not be considered in isolation of, or as an alternative to, measures prepared in accordance with GAAP. There are a number of limitations related to the use of Adjusted EBITDA, Adjusted Net Income, Adjusted Basic EPS, and Adjusted Diluted EPS rather than net income (loss), which is the nearest GAAP equivalent of Adjusted EBITDA and Adjusted Net Income, or Basic EPS and Diluted EPS, which is the nearest equivalent to Adjusted Basic EPS and Adjusted Diluted EPS. These limitations include that the non-GAAP financial measures: (i) exclude depreciation and amortization, and although these are non-cash expenses, the assets being depreciated may be replaced in the future; (ii) do not reflect interest expense, or the cash requirements necessary to service interest on debt, which reduces cash available; (iii) do not reflect the provision for or benefit from income tax that may result in payments that reduce cash available; (iv) exclude non-recurring items (i.e., the extinguishment of debt); and (v) may not be comparable to similar non-GAAP financial measures used by other companies, because the expenses and other items that Janus excludes in the calculation of these non-GAAP financial measures may differ from the expenses and other items, if any, that other companies may exclude from these non-GAAP financial measures when they report their operating results. Because of these limitations, these non-GAAP financial measures should be considered along with other operating and financial performance measures presented in accordance with GAAP.
Consolidated Statements of Operations and Comprehensive Income (Loss) (In thousands) |
|||||||||||||||
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
|
|
|
|
|
|
|
||||||||
|
(Unaudited) |
|
(Unaudited) |
|
(Unaudited) |
|
(Unaudited) |
||||||||
REVENUE |
|
|
|
|
|
|
|
||||||||
Sales of product |
$ |
230,847 |
|
|
$ |
155,670 |
|
|
$ |
642,122 |
|
|
$ |
417,922 |
|
Sales of services |
|
31,700 |
|
|
|
32,120 |
|
|
|
97,659 |
|
|
|
96,874 |
|
Total revenue |
|
262,547 |
|
|
|
187,790 |
|
|
|
739,781 |
|
|
|
514,796 |
|
Cost of Sales |
|
165,755 |
|
|
|
125,551 |
|
|
|
482,439 |
|
|
|
340,070 |
|
GROSS PROFIT |
|
96,792 |
|
|
|
62,239 |
|
|
|
257,342 |
|
|
|
174,726 |
|
OPERATING EXPENSE |
|
|
|
|
|
|
|
||||||||
Selling and marketing |
|
14,477 |
|
|
|
12,066 |
|
|
|
42,216 |
|
|
|
31,906 |
|
General and administrative |
|
28,418 |
|
|
|
24,947 |
|
|
|
86,267 |
|
|
|
81,469 |
|
Contingent consideration and earnout fair value adjustments |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
687 |
|
Operating Expenses |
|
42,895 |
|
|
|
37,013 |
|
|
|
128,483 |
|
|
|
114,062 |
|
INCOME FROM OPERATIONS |
|
53,897 |
|
|
|
25,226 |
|
|
|
128,859 |
|
|
|
60,664 |
|
Interest expense |
|
(10,979 |
) |
|
|
(7,664 |
) |
|
|
(28,622 |
) |
|
|
(23,265 |
) |
Other expense |
|
56 |
|
|
|
91 |
|
|
|
(313 |
) |
|
|
(2,388 |
) |
Change in fair value of derivative warrant liabilities |
|
— |
|
|
|
1,271 |
|
|
|
— |
|
|
|
(658 |
) |
INCOME BEFORE TAXES |
|
42,974 |
|
|
|
18,924 |
|
|
|
99,924 |
|
|
|
34,353 |
|
Provision for Income Taxes |
|
10,575 |
|
|
|
3,382 |
|
|
|
24,984 |
|
|
|
5,787 |
|
NET INCOME |
$ |
32,399 |
|
|
$ |
15,542 |
|
|
$ |
74,940 |
|
|
$ |
28,566 |
|
Other Comprehensive Income (Loss) |
|
(3,037 |
) |
|
|
(1,170 |
) |
|
|
(6,938 |
) |
|
|
(896 |
) |
COMPREHENSIVE INCOME |
$ |
29,362 |
|
|
$ |
14,372 |
|
|
$ |
68,002 |
|
|
$ |
27,670 |
|
Net income attributable to common stockholders |
$ |
32,399 |
|
|
$ |
15,542 |
|
|
$ |
74,940 |
|
|
$ |
28,566 |
|
Weighted-average shares outstanding, basic and diluted |
|
|
|
|
|
|
|
||||||||
Basic |
|
146,639,452 |
|
|
|
138,384,284 |
|
|
|
146,592,296 |
|
|
|
95,179,726 |
|
Diluted |
|
146,717,917 |
|
|
|
142,840,792 |
|
|
|
146,671,509 |
|
|
|
97,828,380 |
|
Net income (loss) per share, basic and diluted |
|
|
|
|
|
|
|
||||||||
Basic |
$ |
0.22 |
|
|
$ |
0.11 |
|
|
$ |
0.51 |
|
|
$ |
0.30 |
|
Diluted |
$ |
0.22 |
|
|
$ |
0.10 |
|
|
$ |
0.51 |
|
|
$ |
0.30 |
|
Consolidated Balance Sheets (In thousands) |
|||||||
|
|
|
|
||||
|
|
2022 |
|
|
|
2022 |
|
|
(Unaudited) |
|
|
||||
ASSETS |
|
|
|
||||
Current Assets |
|
|
|
||||
Cash |
$ |
55,335 |
|
|
$ |
13,192 |
|
Accounts receivable, less allowance for credit losses; |
$ |
151,694 |
|
|
$ |
107,372 |
|
Costs and estimated earnings in excess of billing on uncompleted contracts |
$ |
30,831 |
|
|
$ |
23,121 |
|
Inventory, net |
$ |
69,050 |
|
|
$ |
56,596 |
|
Prepaid expenses |
$ |
12,282 |
|
|
$ |
9,843 |
|
Other current assets |
$ |
2,227 |
|
|
$ |
4,057 |
|
Total current assets |
$ |
321,419 |
|
|
$ |
214,181 |
|
Right-of-use assets, net |
$ |
45,529 |
|
|
$ |
— |
|
Property and equipment, net |
$ |
42,855 |
|
|
$ |
41,607 |
|
Customer relationships, net |
$ |
288,770 |
|
|
$ |
312,199 |
|
Tradename and trademarks |
$ |
106,971 |
|
|
$ |
107,980 |
|
Other intangibles, net |
$ |
14,743 |
|
|
$ |
15,861 |
|
|
$ |
367,262 |
|
|
$ |
369,286 |
|
Deferred tax asset, net |
$ |
59,979 |
|
|
$ |
58,915 |
|
Other assets |
$ |
1,874 |
|
|
$ |
1,973 |
|
Total assets |
$ |
1,249,402 |
|
|
$ |
1,122,002 |
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
||||
Current Liabilities |
|
|
|
||||
Accounts payable |
$ |
55,728 |
|
|
$ |
54,961 |
|
Billing in excess of costs and estimated earnings on uncompleted contracts |
$ |
27,235 |
|
|
$ |
23,207 |
|
Current maturities of long-term debt |
$ |
8,379 |
|
|
$ |
8,067 |
|
Other accrued expenses |
$ |
75,919 |
|
|
$ |
54,111 |
|
Total current liabilities |
$ |
167,261 |
|
|
$ |
140,346 |
|
Line of credit |
$ |
— |
|
|
$ |
6,369 |
|
Long-term debt, net |
$ |
701,189 |
|
|
$ |
703,718 |
|
Deferred tax liability, net |
$ |
1,678 |
|
|
$ |
749 |
|
Other long-term liabilities |
$ |
41,764 |
|
|
$ |
2,533 |
|
Total liabilities |
$ |
911,892 |
|
|
$ |
853,715 |
|
STOCKHOLDERS’ EQUITY |
|
|
|
||||
Common Stock, 825,000,000 shares authorized, |
$ |
15 |
|
|
$ |
15 |
|
Additional paid-in capital |
$ |
279,944 |
|
|
$ |
277,799 |
|
Accumulated other comprehensive loss |
$ |
(7,887 |
) |
|
$ |
(949 |
) |
Retained earnings (accumulated deficit) |
$ |
65,438 |
|
|
$ |
(8,578 |
) |
Total stockholders’ equity |
$ |
337,510 |
|
|
$ |
268,287 |
|
Total liabilities and stockholders’ equity |
$ |
1,249,402 |
|
|
$ |
1,122,002 |
|
Consolidated Statements of Cash Flows (In thousands) |
|||||||
|
Nine Months Ended |
||||||
|
|
|
|
||||
|
(Unaudited) |
|
(Unaudited) |
||||
Cash Flows Provided By Operating Activities |
|
|
|
||||
Net income |
$ |
74,940 |
|
|
$ |
28,566 |
|
Adjustments to reconcile net income to net cash provided by operating activities |
|
|
|
||||
Depreciation of property and equipment |
|
5,817 |
|
|
|
4,678 |
|
Reduction in carrying amount of right-of-use assets |
|
3,997 |
|
|
|
— |
|
Amortization of intangibles |
|
22,278 |
|
|
|
21,852 |
|
Deferred finance fee amortization |
|
2,758 |
|
|
|
2,286 |
|
Provision (reversal) for losses on accounts receivable |
|
1,206 |
|
|
|
(59 |
) |
Share based compensation |
|
2,145 |
|
|
|
5,262 |
|
Loss on extinguishment of debt |
|
— |
|
|
|
2,415 |
|
Change in fair value of contingent consideration |
|
— |
|
|
|
687 |
|
(Gain) loss on sale of assets |
|
(45 |
) |
|
|
43 |
|
Loss on abandonment of lease |
|
571 |
|
|
|
— |
|
Change in fair value of derivative warrant liabilities |
|
— |
|
|
|
658 |
|
Undistributed (earnings) losses of affiliate |
|
(102 |
) |
|
|
76 |
|
Deferred income taxes, net |
|
— |
|
|
|
(768 |
) |
Changes in operating assets and liabilities |
|
|
|
||||
Accounts receivable |
|
(45,893 |
) |
|
|
(16,884 |
) |
Costs and estimated earnings in excess of billings and billings in excess of costs and estimated earnings on uncompleted contracts |
|
(7,710 |
) |
|
|
(12,101 |
) |
Prepaid expenses and other current assets |
|
(531 |
) |
|
|
(4,488 |
) |
Inventory, net |
|
(12,454 |
) |
|
|
(18,474 |
) |
Accounts payable |
|
766 |
|
|
|
18,409 |
|
Other accrued expenses |
|
17,658 |
|
|
|
28,649 |
|
Other assets and long-term liabilities |
|
(2,810 |
) |
|
|
(1,124 |
) |
Net Cash Provided By Operating Activities |
$ |
62,591 |
|
|
$ |
59,683 |
|
Cash Flows Used In Investing Activities |
|
|
|
||||
Proceeds from sale of equipment |
$ |
67 |
|
|
$ |
79 |
|
Purchases of property and equipment |
|
(7,856 |
) |
|
|
(15,930 |
) |
Cash paid for acquisition, net of cash acquired |
|
— |
|
|
|
(179,714 |
) |
|
$ |
(7,789 |
) |
|
$ |
(195,565 |
) |
Cash Flows Used In Financing Activities |
|
|
|
||||
(Repayments) proceeds from line of credit |
$ |
(6,369 |
) |
|
$ |
19,351 |
|
Distributions to |
|
— |
|
|
|
(4,174 |
) |
Principal payments on long-term debt |
|
(6,051 |
) |
|
|
(64,825 |
) |
Proceeds from long-term debt |
|
— |
|
|
|
155,000 |
|
Proceeds from merger |
|
— |
|
|
|
334,874 |
|
Proceeds from PIPE |
|
— |
|
|
|
250,000 |
|
Payments for transaction costs, net |
|
— |
|
|
|
(44,489 |
) |
Payments to |
|
— |
|
|
|
(541,710 |
) |
Proceeds from warrant exercise |
|
— |
|
|
|
1 |
|
Principal payments under finance lease obligations |
|
(137 |
) |
|
|
— |
|
Payments for deferred financing fees |
|
— |
|
|
|
(4,321 |
) |
Cash (Used In) Provided by Financing Activities |
$ |
(12,557 |
) |
|
$ |
99,707 |
|
Effect of exchange rate changes on cash and cash equivalents |
$ |
(102 |
) |
|
$ |
142 |
|
Net Increase (Decrease) in Cash and Cash Equivalents |
$ |
42,143 |
|
|
$ |
(36,033 |
) |
Cash and Cash Equivalents, Beginning of Period |
$ |
13,192 |
|
|
$ |
45,255 |
|
Cash and Cash Equivalents, End of Period |
$ |
55,335 |
|
|
$ |
9,222 |
|
Supplemental Cash Flows Information |
|
|
|
||||
Interest paid |
$ |
28,351 |
|
|
$ |
19,227 |
|
Income taxes paid |
$ |
21,655 |
|
|
$ |
1,510 |
|
Cash paid for operating leases |
$ |
5,763 |
|
|
$ |
— |
|
Fair value of earnout |
$ |
— |
|
|
$ |
687 |
|
Fair value of warrants |
$ |
— |
|
|
$ |
658 |
|
Non-cash investing and financing activities: |
|
|
|
||||
Right-of-use assets obtained in exchange for operating lease obligations |
$ |
47,999 |
|
|
$ |
— |
|
Right-of-use assets obtained in exchange for finance lease obligations |
$ |
1,373 |
|
|
$ |
— |
|
Reconciliation of Net Income to Adjusted EBITDA (In thousands) |
||||||||||||||
|
Three Months Ended |
|
|
|
|
|||||||||
|
|
|
|
|
Variance |
|||||||||
|
|
|
|
|
$ |
|
% |
|||||||
Net Income |
$ |
32,399 |
|
|
$ |
15,542 |
|
|
$ |
16,857 |
|
|
108.5 |
% |
Interest Expense |
|
10,979 |
|
|
|
7,664 |
|
|
|
3,315 |
|
|
43.3 |
% |
Income Taxes |
|
10,575 |
|
|
|
3,382 |
|
|
|
7,193 |
|
|
212.7 |
% |
Depreciation |
|
1,982 |
|
|
|
1,699 |
|
|
|
283 |
|
|
16.7 |
% |
Amortization |
|
7,408 |
|
|
|
8,229 |
|
|
|
(821 |
) |
|
(10.0 |
)% |
EBITDA |
$ |
63,343 |
|
|
$ |
36,516 |
|
|
$ |
26,827 |
|
|
73.5 |
% |
Loss (gain) on extinguishment of debt(1) |
|
— |
|
|
|
— |
|
|
|
— |
|
|
100.0 |
% |
COVID-19 related expenses(2) |
|
— |
|
|
|
1,030 |
|
|
|
(1,030 |
) |
|
(100.0 |
)% |
Transaction related expenses(3) |
|
— |
|
|
|
— |
|
|
|
— |
|
|
100.0 |
% |
Facility relocation(4) |
|
— |
|
|
|
35 |
|
|
|
(35 |
) |
|
(100.0 |
)% |
Share-based compensation(5) |
|
— |
|
|
|
— |
|
|
|
— |
|
|
100.0 |
% |
Acquisition expense(6) |
|
(40 |
) |
|
|
— |
|
|
|
(40 |
) |
|
100.0 |
% |
Severance and transition costs (7) |
|
— |
|
|
|
— |
|
|
|
— |
|
|
100.0 |
% |
Change in fair value of contingent consideration(8) |
|
— |
|
|
|
— |
|
|
|
— |
|
|
100.0 |
% |
Change in fair value of derivative warrant liabilities(9) |
|
— |
|
|
|
(1,271 |
) |
|
|
1,271 |
|
|
(100.0 |
)% |
Adjusted EBITDA |
$ |
63,303 |
|
|
$ |
36,310 |
|
|
$ |
26,993 |
|
|
74.3 |
% |
|
Nine Months Ended |
|
|
|
|
|||||||
|
|
|
|
|
Variance |
|||||||
|
|
|
|
|
$ |
|
% |
|||||
Net Income |
$ |
74,940 |
|
$ |
28,566 |
|
$ |
46,374 |
|
|
162.3 |
% |
Interest Expense |
|
28,622 |
|
|
23,265 |
|
|
5,357 |
|
|
23.0 |
% |
Income Taxes |
|
24,984 |
|
|
5,787 |
|
|
19,197 |
|
|
331.7 |
% |
Depreciation |
|
5,817 |
|
|
4,678 |
|
|
1,139 |
|
|
24.3 |
% |
Amortization |
|
22,278 |
|
|
21,852 |
|
|
426 |
|
|
1.9 |
% |
EBITDA |
$ |
156,641 |
|
$ |
84,148 |
|
$ |
72,493 |
|
|
86.1 |
% |
Loss (gain) on extinguishment of debt(1) |
|
— |
|
|
2,415 |
|
|
(2,415 |
) |
|
(100.0 |
)% |
COVID-19 related expenses(2) |
|
109 |
|
|
1,240 |
|
|
(1,131 |
) |
|
(91.2 |
)% |
Transaction related expenses(3) |
|
— |
|
|
10,398 |
|
|
(10,398 |
) |
|
(100.0 |
)% |
Facility relocation(4) |
|
620 |
|
|
102 |
|
|
518 |
|
|
507.8 |
% |
Share-based compensation(5) |
|
— |
|
|
5,210 |
|
|
(5,210 |
) |
|
(100.0 |
)% |
Acquisition expense(6) |
|
782 |
|
|
— |
|
|
782 |
|
|
100.0 |
% |
Severance and transition costs (7) |
|
500 |
|
|
— |
|
|
500 |
|
|
100.0 |
% |
Change in fair value of contingent consideration(8) |
|
— |
|
|
687 |
|
|
(687 |
) |
|
(100.0 |
)% |
Change in fair value of derivative warrant liabilities(9) |
|
— |
|
|
658 |
|
|
(658 |
) |
|
(100.0 |
)% |
Adjusted EBITDA |
$ |
158,652 |
|
$ |
104,858 |
|
$ |
53,794 |
|
|
51.3 |
% |
(1) |
Adjustment for loss (gain) on extinguishment of debt regarding the write off of unamortized fees and third-party fees as a result of the debt modification completed in |
|
(2) |
Expenses which are one-time and non-recurring related to the COVID-19 pandemic. See Impact of COVID-19 section. | |
(3) |
Transaction related expenses incurred as a result of the Business Combination on |
|
(4) |
Expenses related to the facility relocation for ASTA and |
|
(5) |
Share-based compensation expense associated with Midco, LLC Class |
|
(6) |
Expenses related to the transition services agreement for the DBCI acquisition which closed |
|
(7) |
Reflects one-time costs associated with our strategic transformation, including executive leadership team changes, strategic business assessment and transformation projects. | |
(8) |
Adjustment related to the change in fair value of contingent consideration related to the earnout of the 2,000,000 common stock shares that were issued and released on |
|
(9) |
Adjustment related to the change in fair value of derivative warrant liabilities for the private placement warrants. |
Reconciliation of Net Income to Non-GAAP Adjusted Net Income (In thousands) |
|||||||
|
Three Months Ended |
||||||
|
|
|
|
||||
Net Income (Loss) |
$ |
32,399 |
|
|
$ |
15,542 |
|
Net Income Adjustments(1) |
|
(40 |
) |
|
|
(206 |
) |
Tax Effect Non-GAAP on Net Income Adjustments(2) |
|
(10 |
) |
|
|
(37 |
) |
Non-GAAP Adjusted Net Income |
$ |
32,349 |
|
|
$ |
15,299 |
|
|
Nine Months Ended |
||||
|
|
|
|
||
Net Income |
$ |
74,940 |
|
$ |
28,566 |
Net Income Adjustments(1) |
|
2,011 |
|
|
20,710 |
Tax Effect Non-GAAP on Net Income Adjustments(2) |
|
503 |
|
|
3,489 |
Non-GAAP Adjusted Net Income |
$ |
77,454 |
|
$ |
52,765 |
(1) |
Refer to |
|
(2) |
Tax effected for the net income adjustments. Used effective tax rates |
Non-GAAP Adjusted EPS (In thousands) |
|||||
|
|
||||
|
Three Months Ended |
||||
|
|
|
|
||
Numerator: |
|
|
|
||
Non-GAAP Adjusted Net Income |
$ |
32,349 |
|
$ |
15,299 |
Denominator: |
|
|
|
||
Weighted average number of shares: |
|
|
|
||
Basic |
|
146,639,452 |
|
|
138,384,284 |
Adjustment for Restricted Stock Units |
|
78,465 |
|
|
4,456,508 |
Diluted |
|
146,717,917 |
|
|
142,840,792 |
Non-GAAP Adjusted Basic EPS |
$ |
0.22 |
|
$ |
0.11 |
Non-GAAP Adjusted Diluted EPS |
$ |
0.22 |
|
$ |
0.11 |
|
Nine Months Ended |
||||
|
|
|
|
||
Numerator: |
|
|
|
||
Non-GAAP Adjusted Net Income |
$ |
77,454 |
|
$ |
52,765 |
Denominator: |
|
|
|
||
Weighted average number of shares: |
|
|
|
||
Basic |
|
146,592,296 |
|
|
95,179,726 |
Adjustment for Restricted Stock Units |
|
79,213 |
|
|
2,648,654 |
Diluted |
|
146,671,509 |
|
|
97,828,380 |
Non-GAAP Adjusted Basic EPS |
$ |
0.53 |
|
$ |
0.55 |
Non-GAAP Adjusted Diluted EPS |
$ |
0.53 |
|
$ |
0.54 |
Non-GAAP Free Cash Flow Conversion (In thousands) |
|||||||
|
Three Months Ended |
||||||
|
|
|
|
||||
Cash flow from operating activities |
|
19,437 |
|
|
|
14,860 |
|
Less capital expenditure |
|
(2,588 |
) |
|
|
(11,938 |
) |
Free cash flow |
$ |
16,849 |
|
|
$ |
2,922 |
|
|
|
|
|
||||
Non-GAAP Adjusted Net Income |
$ |
32,349 |
|
|
$ |
15,299 |
|
|
|
|
|
||||
Free cash flow conversion of Non-GAAP Adjusted Net Income |
|
52 |
% |
|
|
19 |
% |
|
Nine Months Ended |
||||||
|
|
|
|
||||
Cash flow from operating activities |
$ |
62,591 |
|
|
$ |
59,683 |
|
Less capital expenditure |
|
(7,856 |
) |
|
|
(15,930 |
) |
Free cash flow |
$ |
54,735 |
|
|
$ |
43,753 |
|
|
|
|
|
||||
Non-GAAP Adjusted Net Income |
$ |
77,454 |
|
|
$ |
52,765 |
|
|
|
|
|
||||
Free cash flow conversion of Non-GAAP Adjusted Net Income |
|
71 |
% |
|
|
83 |
% |
View source version on businesswire.com: https://www.businesswire.com/news/home/20221110005274/en/
Investor Contacts, Janus
Vice President, Investor Relations & FP&A,
IR@janusintl.com
(770) 562-6399
Media Contacts, Janus
Marketing Content Manager,
770-746-9576
Marketing@Janusintl.com
Source:
FAQ
What were Janus International's Q3 2022 earnings?
How much did Adjusted EBITDA grow for Janus in Q3 2022?
What is the new revenue outlook for Janus International in 2022?
What factors contributed to Janus International's financial growth?